This grand round has already taken place.
Colorectal cancer (CRC) is the second most commonly diagnosed cancer among females and third among males worldwide. Biomarkers currently play an important role in the detection and treatment of patients with colorectal cancer. There are attempts to personalize chemotherapy based on presence or absence of specific biomarkers. In this talk, I will describe current understanding of tumor markers and biomarkers role in CRC screening, diagnosis, treatment, and follow-up.
Dates and Times
Start: 11/1/2017 12:00 PM
End: 11/1/2017 1:00 PM
1) How to test for a MMR deficient tumor
2) Molecular subtype of colorectal cancer
3) Predictive biomarkers for immunotherapy of colorectal cancer
Level 2, Room 749
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.